Page 3 - Hong Kong (HSI) Growth Healthcare Stocks

UPDATED Apr 24, 2024

Discover Hong Kong Healthcare Growth Stocks that are on the HSI. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.

107 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

718

Tai United Holdings
HK$0.030%-49.2%HK$157.5mn/aPE-0.09xn/a0%

9877

Jenscare Scientific
HK$4.19-4.1%-89.0%HK$1.7bHK$42.94PB1.3xS48.6%n/a

3886

Town Health International Medical Group
HK$0.28-3.4%-8.2%HK$1.9bn/aPS1xn/a0.4%

673

China Health Group
HK$0.917.1%-18.8%HK$435.9mn/aPS5.9xn/an/a

1931

IVD Medical Holding
HK$2.271.3%66.9%HK$3.1bn/aPE11.9xn/a4.0%

2159

Mediwelcome Healthcare Management & Technology
HK$0.41-4.7%-55.4%HK$82.0mn/aPB0.7xn/an/a

1120

Arts Optical International Holdings
HK$0.81-2.4%-1.2%HK$312.9mn/aPE6.1xn/a6.2%

2291

LEPU ScienTech Medical Technology (Shanghai)
HK$22.00-5.2%-14.6%HK$7.6bn/aPE46.6xn/a2.8%

8372

Grand Brilliance Group Holdings
HK$0.095-6.9%18.8%HK$76.0mn/aPE9.7xn/a4.2%

8143

Good Fellow Healthcare Holdings
HK$0.19-19.2%17.6%HK$113.2mn/aPS2.1xn/an/a

3689

Guangdong Kanghua Healthcare
HK$2.09-0.5%-3.2%HK$698.9mn/aPE5.3xn/a0%

1518

New Century Healthcare Holding
HK$0.822.5%70.8%HK$401.8mn/aPE4.4xn/a4.6%

2293

Bamboos Health Care Holdings
HK$0.62-3.1%-16.2%HK$249.5mn/aPE7.5xn/a12.1%

2189

Kato (Hong Kong) Holdings
HK$0.540%-10.0%HK$540.0mn/aPE6.1xn/a3.7%

2415

MedSci Healthcare Holdings
HK$2.48-3.5%-73.0%HK$1.3bn/aPE22.3xn/an/a

574

Pa Shun International Holdings
HK$0.043-10.4%n/aHK$70.8mn/aPE25xn/a0%

2170

Suzhou Basecare Medical
HK$2.035.7%-58.6%HK$531.8mHK$12.24PS2.4xn/an/a

2211

Universal Health International Group Holding
HK$0.043-20.4%-70.3%HK$28.7mn/aPB0.08xn/a0%

1110

Kingworld Medicines Group
HK$0.533.9%-33.8%HK$329.9mn/aPE8xn/a6.4%

2393

Yestar Healthcare Holdings
HK$0.0452.3%-85.0%HK$104.9mn/aPE-10.4xn/a0%

1134

Kelfred Holdings
HK$0.400%-16.0%HK$197.5mn/aPE142.3xn/a0%

9885

YSB
HK$7.930.3%n/aHK$5.1bn/aPB2.5xn/an/a

2289

Charmacy Pharmaceutical
HK$13.9820.9%78.8%HK$1.5bn/aPE27.2xn/a2.3%

2427

Guanze Medical Information Industry (Holding)
HK$0.882.3%128.6%HK$836.0mn/aPE28.1xn/a2.4%
Page 3 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.